Literature DB >> 8110509

Phase II study of D-verapamil and doxorubicin in patients with metastatic colorectal cancer.

W Scheithauer, G Kornek, J Kastner, M Raderer, G Locker, D Depisch, J Pidlich, C Tetzner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8110509     DOI： 10.1016/0959-8049(93)90235-8

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  1 in total

1.  Treatment of advanced colorectal cancer with doxorubicin combined with two potential multidrug-resistance-reversing agents: high-dose oral tamoxifen and dexverapamil.

Authors:  G Weinländer; G Kornek; M Raderer; M Hejna; C Tetzner; W Scheithauer
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.